Evening Preference Linked to Higher BMI in Type 2 Diabetes

Share this content:
Evening Preference Linked to Higher BMI in Type 2 Diabetes
Evening Preference Linked to Higher BMI in Type 2 Diabetes

TUESDAY, April 24, 2018 (HealthDay News) -- Evening preference and a later breakfast are associated with elevated body mass index (BMI) in adults with type 2 diabetes, according to a study published online April 13 in Diabetic Medicine.

Hataikarn Nimitphong, M.D., from Mahidol University in Bangkok, and colleagues examined the correlations among meal timing, morning-evening preference, and BMI in 210 non-shift workers with type 2 diabetes. Morning-evening preference was assessed using the Composite Scale of Morningness, while one-day food recall was used to assess meal timing and daily calorie intake.

The researchers found that a higher BMI was correlated with greater evening preference (P = 0.019) and with late breakfast time (P = 0.053). There were no correlations for BMI with other mealtimes or calorie intake. Evening preference was significantly associated with late breakfast time (P < 0.001). The correlation between morning-evening preference and BMI was mediated by breakfast time; morning preference was correlated with earlier breakfast time and 0.37 kg/m² lower BMI. There was a non-significant correlation for the direct relationship between BMI and morning-evening preference.

"These results suggest that circadian preference and meal timing are novel and possibly modifiable risk factors for obesity in type 2 diabetes," the authors write.

Two authors disclosed financial ties to the pharmaceutical industry.

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Moves to Restrict Flavored E-Cig Sales, Ban Menthol Cigarettes

FDA Moves to Restrict Flavored E-Cig Sales, Ban ...

The move stops short of the full ban on e-cigarettes that had been expected

Name-Brand Medications Driving Spike in U.S. Drug Spending

Name-Brand Medications Driving Spike in U.S. Drug Spending

Greatest costs for Humira, Remicade, Enbrel, Novolog, and Neulasta

is free, fast, and customized just for you!




Already a member?

Sign In Now »